What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Internal medicine
Masaki Otagiri spends much of his time researching Biochemistry, Human serum albumin, Serum albumin, Albumin and Binding site.
Masaki Otagiri interconnects Kidney and Pharmacology in the investigation of issues within Biochemistry.
His Human serum albumin study incorporates themes from Recombinant DNA, Ligand, Ultrafiltration, Stereochemistry and Allosteric regulation.
His research in Serum albumin focuses on subjects like Structure–activity relationship, which are connected to Hypoalbuminemia.
The study incorporates disciplines such as Amino acid, S-Nitrosylation, Blood proteins, Dimer and Drug carrier in addition to Albumin.
His work in Binding site tackles topics such as Drug which are related to areas like Glycoprotein.
His most cited work include:
- Structural Basis of the Drug-Binding Specificity of Human Serum Albumin. (1234 citations)
- Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin (664 citations)
- Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin (282 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Biochemistry, Human serum albumin, Pharmacology, Albumin and Internal medicine.
Much of his study explores Biochemistry relationship to In vivo.
His Human serum albumin research is multidisciplinary, relying on both Recombinant DNA, Nitric oxide, Stereochemistry, Serum albumin and Binding site.
His work in Internal medicine addresses issues such as Endocrinology, which are connected to fields such as Microsome.
His work focuses on many connections between Pharmacokinetics and other disciplines, such as Chromatography, that overlap with his field of interest in Solubility, Absorption and Drug.
The Oxidative stress study combines topics in areas such as Reactive oxygen species and Antioxidant.
He most often published in these fields:
- Biochemistry (46.05%)
- Human serum albumin (30.10%)
- Pharmacology (26.35%)
What were the highlights of his more recent work (between 2012-2021)?
- Biochemistry (46.05%)
- Pharmacology (26.35%)
- Human serum albumin (30.10%)
In recent papers he was focusing on the following fields of study:
His main research concerns Biochemistry, Pharmacology, Human serum albumin, Albumin and Oxidative stress.
His Nitric oxide research extends to Biochemistry, which is thematically connected.
His Pharmacology study combines topics in areas such as Red blood cell, Immunology and Idiopathic pulmonary fibrosis.
His Human serum albumin research integrates issues from Plasma protein binding, In vitro, Circular dichroism, Blood proteins and Binding site.
His Binding site study combines topics from a wide range of disciplines, such as Stereochemistry and Drug.
His research in Oxidative stress intersects with topics in Reactive oxygen species, Superoxide and Antioxidant.
Between 2012 and 2021, his most popular works were:
- Albumin-drug interaction and its clinical implication. (214 citations)
- p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase (184 citations)
- Redox properties of serum albumin (111 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Biochemistry
His primary scientific interests are in Biochemistry, Human serum albumin, Oxidative stress, Pharmacology and Albumin.
As part of his studies on Biochemistry, Masaki Otagiri often connects relevant areas like Enhanced permeability and retention effect.
His Human serum albumin research is multidisciplinary, incorporating perspectives in Plasma protein binding, Stereochemistry, Circular dichroism, Chronic liver disease and Serum albumin.
His Serum albumin research is multidisciplinary, relying on both Nitric oxide and Binding site.
His Oxidative stress research is multidisciplinary, incorporating elements of Reactive oxygen species, Superoxide and Antioxidant.
His research integrates issues of Liposome, Pharmacokinetics, Dimer and Drug in his study of Albumin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
